Fundraising FoxTeraPore Technologies
South San Francisco, US · Founded 2013 · Delaware corporation · 3 known investors
Find your way into TeraPore Technologies
Each arrow is one introduction. Sign up to fill in the first one.
Ask Karen Law to introduce you to Rachel M. Dorin
You →Karen · together at Sandia National Laboratories →Rachel
Sign up to find every way you can get introduced to TeraPore Technologies
- Your email: who you already know at TeraPore Technologies, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the TeraPore Technologies team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
TeraPore develops nanofiltration products based on self-assembled block copolymer membrane technology for critical separation applications, including virus filtration for therapeutic proteins and biologics and semiconductor manufacturing. Its IsoBlock VF product is an isoporous membrane designed for viral clearance across antibody constructs for biopharmaceutical manufacturers.
Founders & leadership
TeraPore Technologies was founded in 2013 by Rachel M. Dorin.
Board
Investors · 3
How we know: Anzu Partners's portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$13.5M disclosed across 3 rounds · 2016–2023
- $10MraisedMar 2023 · 2 sourcesSource ↗
▶$1.8MraisedJan 2018 · 4 investors · BiotechnologyRule 506(b)
- Stuart BerkowitzDirector
- David SeldinDirector
- Mark HurwitzDirector
- David MichaelDirector
- Rachel DorinExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.8M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.8MraisedJun 2016 · 8 investors · BiotechnologyRule 506(b)
- Stuart BerkowitzDirector
- David SeldinDirector
- Rachel M. DorinExecutive Officer, Director
- David MichaelDirector
- Mark HurwitzDirector
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as TeraPore Technologies.
In the news
Frequently asked questions
- What does TeraPore Technologies do?
- TeraPore develops nanofiltration products based on self-assembled block copolymer membrane technology for critical separation applications, including virus filtration for therapeutic proteins and biologics and semiconductor manufacturing. Its IsoBlock VF product is an isoporous membrane designed for viral clearance across antibody constructs for biopharmaceutical manufacturers.
- Who founded TeraPore Technologies?
- TeraPore Technologies was founded by Rachel M. Dorin in 2013.
- Who are TeraPore Technologies's investors?
- TeraPore Technologies's investors include Anzu Partners, Artiman Ventures, RA Capital.
- How much funding has TeraPore Technologies raised?
- TeraPore Technologies has disclosed $13.5M raised across 3 rounds.
- Where is TeraPore Technologies headquartered?
- TeraPore Technologies is headquartered in South San Francisco, US.